chrisvoncsefalvay/vaers-outcomes huggingface dataset:
slightly sore arm; unable to push self nearly as much as usual, want overly tired, but unable to workout intensely for over 2 hours for a week+. And a workout of this length of usually very easy; unable to push self nearly as much as usual, want overly tired, but unable to workout intensely for over 2 hours for a week+. And a workout of this length of usually very easy/ want able to find anydata on extreme endurance.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the right arm on 30Mar2021 at 12:00 (at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Apr2021 at 08:00, the patient noticed no immediate effects besides a slightly sore arm. The patient described himself as an extreme endurance athlete. The patient took a couple days off of intense exercise, but a few days later had longer works planned (3 plus hours, intense biking). It was very noticeable that patient couldn't get his heart rate up and was unable to push nearly as much as usual. He was overly tired and was unable to workout intensely for over 2 hours for a week plus and a workout of that length was usually very easy. He thought he was fully recovered , just took second shot, but was not able to find any data on extreme endurance. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events slightly sore arm, noticeable that couldn't get heart rate up, was unable to push self nearly as much as usual, want overly tired, but was unable to workout intensely for over 2 hours for a week+ and a workout of this length of usually very easy was resolved on an unknown date in Apr2021. The patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021, as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Rash on face under eyes with some swelling mostly in morning when first wake up/ Rash on right forearm spreading up to bicept/Rash on left hand and ring finger; Rash on face under eyes with some swelling mostly in morning when first wake up; Rash on genital; Very itchy; BNT162b2 was administered on same day when other vaccine (Moderna) was administered; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 19Apr2021 at 15:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. The patient also received COVID-19 vaccine MRNA (MRNA 1273)(MODERNA COVID-19 VACCINE; Lot number: unknown) via an unspecified route of administration on 19Apr2021, for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included ibuprofen (MOTRIN), gabapentin (MANUFACTURER UNKNOWN), naloxone hydrochloride/ buprenorphine hydrochloride (SUBOXONE) and cannabis sativa (MARIJUANA); all for unknown indication from unknown date and unknown if ongoing. On 21Apr2021, the patient experienced rash on face under eyes with some swelling mostly in morning when first woke up. The patient also had rash on right forearm spreading up to bicept, rash on left hand and ring finger, rash on genital and it was very itchy. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with diphenhydramine hydrochloride (BENADRYL) and cortisone cream (MANUFACTURER UNKNOWN). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events rash on face under eyes with some swelling mostly in morning when first wake up/ rash on right forearm spreading up to bicept/rash on left hand and ring finger, rash on genital and very itchy was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a physician concerning a female (age not reported) who on an unspecified date was vaccinated with the first dose of 0.5 ml of HPV rL1 6 11 16 18 VLP vaccine yeast. It was reported that the pt fainted after the injection (date unk). The pt sought unspecified medical attention. AT the time of this report, the pt had recovered from the event (date unk). Additional information has been requested.
Sedation, Myalgia, Arthralgia, Fever, NauseaVomiting, INSOMNIA Narrative:   Other Relevant History:
red circular welt welt which was about the size of a silver dollar; soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (soreness) and URTICARIA (red circular welt welt which was about the size of a silver dollar) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN (soreness). On 14-Feb-2021, the patient experienced URTICARIA (red circular welt welt which was about the size of a silver dollar). At the time of the report, PAIN (soreness) and URTICARIA (red circular welt welt which was about the size of a silver dollar) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment Benadryl
Mom reports febrile, dec appetite, irritable, beginnng the day of vax w/fever of 102 ax x 8 days; Temp of 103.8 ax on the 8th day @ clinic; No other physical findings; tx Ceclor & APAP;
Subsequent panic attacks and left hand tremor.  Patient has had an MRI, EEG, blood work, and is scheduled to meet with a neuropsychologist later this month.
Red, slightly raised rash developed on chest and arm. Diagnosed with shingles at that time. Rash spread to neck, face, upper arms. Started having pain in the left shoulder blade and spread to back, hips, bilateral legs with associated swelling. Laboratory work-up started when patient established care with me on 11/3/2021. Elevated CPK and aldolase levels, ESR and CRP, BNP. Biopsy of rash by dermatology revealed dermatomyositis diagnosis. Treated with high-dose prednisone with minimal relief of symptoms. Now established with Rheumatology and planning to start methotrexate therapy.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age. On an unknown date, an unspecified number of patients were vaccinated with improperly stored ROTATEQ L047158 expiration 09/17/2017. Other therapies included PNEUMOVAX 23 lot # L003227 expiration 13-OCT-2016 (MARRS# 1607USA005549). The temperature was reported as 34 F and time frame of 15 hours 20 minutes. No symptoms were reported. No further information was provided. This is one of several reports from the same reporter. Additional information has been requested.
Mother said that patients lips were swelling after coming home approx. 2 hours after shot given
Worsening of psychotic symptoms after receiving the second dose; Hallucinations and delusions were presented within four weeks; Hallucinations and delusions were presented within four weeks; This is a literature report for the following literature source(s).  A patient (no qualifiers provided) received COVID-19 Vaccine - Manufacturer Unknown, as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine - manufacturer unknown (DOSE 1 SINGLE), for COVID-19 immunisation, reaction(s): "Psychosis after the administration of the first dose".  The following information was reported: PSYCHOTIC SYMPTOM (medically significant), outcome "recovered", described as "Worsening of psychotic symptoms after receiving the second dose"; HALLUCINATION (medically significant), DELUSION (medically significant), outcome "recovered" and all described as "Hallucinations and delusions were presented within four weeks". Therapeutic measures were taken as a result of psychotic symptom, hallucination, delusion.  Clinical information: Worsening of psychotic symptoms after receiving the second dose. Hallucinations and delusions were presented within four weeks and resolved in three days after the administration of antipsychotics.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and BNT162B2. Based on known drug safety profile, there is reasonable possibility of causal association between the event and BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
This spontaneous report as received from a physician via a company representative refers to a 60 year old or older female patient. Pertinent medical history and drug reactions/allergies were not provided. On an unknown date, the patient was vaccinated with a single dose of ZOSTAVAX (lot number not provided), 0.65 ml, subcutaneous injection, in the arm. No co-suspect or concomitant therapies were reported. On an unknown date, the patient developed a shingles outbreak at the ZOSTAVAX injection site after vaccination. The area around the site developed pustules and redness. Redness also spread down the arm approximately 2 inches.On an unknown date, the patient recovered from the adverse events. No treatment or lab diagnostics studies were reported. The patient sought medical attention by the office visit. The causality was not provided. Additional information has been requested.
Info has been received from a physician concerning an 8 year old male who on 9/11/98 was vaccinated with a dose of varicella virus vaccine love. The pt was noted to have an itchy rash and fever believed to be a varicella rash with greater than 2 dozen pox. It was noted the some of the pox were infected. This was diagnosed on 2/28/05. The pt was treated with Keflex. No product quality complaint was involved. The pt's brother had varicella after vaccination with varicella virus vaccine live. Additional info has been requested.
Information has been received from the physician via Market research Agency concerning a 15 year old female patient (race unknown), who were enrolled in the program. The patient had no relevant medical history or concurrent conditions. On an unknown date, the patient was vaccinated with GARDASIL 9 (dose, route and lot # not reported). Another physician told reporter two days ago that following receiving GARDASIL 9, patient suffered "neurological problems that affected her lower extremities. Events were being treated by a chiropractor. No tests were carried out for diagnosis. Action taken with respect to the GARDASIL 9 was reported as none. The outcome of the events was recovered. The reporter considered events to be related to GARDASIL 9. Additional information is not expected because the physician was not willing to be contacted.
This spontaneous report as received from a medical assistant refers to a male patient of unknown age. On 01-MAY-2013 the patient was inadvertently vaccinated with PNEUMOVAX 23 (lot number H010515) 0.1 ml, intradermal in the forearm. On 01-MAY-2013, the are became reddened and raised, but not swollen and measured 3.5 inches by 2.5 inches. No treatment has been given at this time. The patient called to office. No lab diagnostics studies were performed. The outcome of the event was unknown. Additional information has been requested.
I contracted COVID-19 on 02/10/2022 with symptoms of fatigue, shortness of breath, difficulty breathing, chest tightness, cough, fever of 103 at highest point, chills, headache, and congestion. On 02/19/2022 I received monoclonal antibodies and I also took zinc. I was ill for 3 to 4 weeks. I have lingering symptoms of difficulty breathing, chest tightness, and I am needing my rescue inhalers more frequently than ever before.
Pain and swelling at the injection site 12 hours after and continuing and worsening over the next 48 hours and ongoing. Fever of over 100.4, and up to 102 beginning approximately 18 hours after the injection and continuing for the next approximately 36 hours. Body aches and exhaustion beginning approximately 16 hours after injection and continuing for the next 48 hours and ongoing. Nausea and loss of appetite beginning approximately 12 hours after injection and lasting for approximately 24 hours.
Mother, phoned clinic and left a message on 5-04-09. Her call was returned and the following information was received. 29 hours after immunizations were given (5-03-09 @4pm) fever presented at 102 degrees later to 103 degrees. Given Tylenol and Motrin throughout the evening. Right arm was slightly sore and red. Left arm very sore, swollen and red. The morning of 5-04, both arms remain red and sore with pain occurring under left arm and down into rib cage, with no elevation in temperature. Patient was seen by physician today at 1330 who says that lymph nodes under both arms are very swollen. He advised patient to never take a tetanus shot again. Patient responded that in 10 years, technology would have advanced and this reaction may be a moot point.
Pt recvd 1st dose of Hep B vax on 23JUL91 & exp immediate pain in shoulder, neck & back; @ time of report pain persisted but to a much lesser degree;
two weeks after the 1st vaccine cycle started . H as had IUD for 4 years .two after vaccine  cycle started . Pt is feeling psychotic . now one moth later cycle is about to start. Harmons are all over the place.
Provider administered flublok to 17 years old pt. no adverse side effects noted as a result of vaccination
Starting about 12 hours after vaccine I had the expected symptoms of body aches, chills, headache, nausea and low grade temps. At ~ 0500 on 1/14/21 (~18 hrs after vaccine), I woke up as I was in SVT. I was not able to convert myself and had to go to ED for treatment. HR was 232 upon arrival to ED. Prior to administering adenosine, SVT resolved on own. SVT episode lasted ~2hrs.  I have not had a prolonged SVT episode since ablation in 2016. ER doc mentioned that perhaps fever/ illness from vaccine lowered my threshold for going into SVT.
What appeared to be a welt over injection site. It was itchy, red, raised slightly, warm, and hive like. They are calling it ?covid arm? when researched. It appeared one week after the shot was administered and stayed for four days. I did not take any medicine besides Tylenol. I also had a swollen lymph node in the same armpit for a couple of days.
Information has been received from a physician concerning a 63 year old female who on 02-JUN-2008 was vaccinated subcutaneously with a 0.65 ml dose of ZOSTAVAX. On 17-JUN-2008 the patient experienced pins and needles on her skin, neuropathic pain on her thoracic dermatome and sever skin irritation. At the time of this report, the patient was recovering. The patient sought unspecified medical attention. Additional information has been requested.
hypotonic/hyporesponsive synd began 30 hr p/vax & resolved by 60 hr p/vax;
This case was reported by a consumer (also a sales representative) and described the occurrence of injection site hemorrhage in a 40-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included penicillin allergy and sulfa allergy. Concurrent medications included IBUPROFEN. On 10 March 2009 at 16:00 the subject received 1st dose of TWINRIX in the left arm. Immediately after vaccination with TWINRIX, the subject experienced a significant amount of bleeding. The physician applied pressure and then placed a band-aid on it. On 10 March 2009, the event resolved while the subject was still in office.
Choked; Patient fainted; Began seizing for about 5 seconds; She began foaming saliva; hypotonia; Became limp; This case was received via FDA VAERS (Reference number: 1198924) on 08-Jun-2021 and was forwarded to Moderna on 08-Jun-2021.    This regulatory authority case was reported by a health care professional and describes the occurrence of CHOKING (Choked), SYNCOPE (Patient fainted) and SEIZURE (Began seizing for about 5 seconds) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced CHOKING (Choked) (seriousness criterion medically significant), SYNCOPE (Patient fainted) (seriousness criterion medically significant), SEIZURE (Began seizing for about 5 seconds) (seriousness criterion medically significant), FOAMING AT MOUTH (She began foaming saliva), HYPOTONIA (hypotonia) and GAIT DISTURBANCE (Became limp). At the time of the report, CHOKING (Choked), SYNCOPE (Patient fainted), SEIZURE (Began seizing for about 5 seconds), FOAMING AT MOUTH (She began foaming saliva), HYPOTONIA (hypotonia) and GAIT DISTURBANCE (Became limp) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and treatment information was not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
About 20 minutes after I started having difficulty swallowing, felt like throat was getting slightly tighter.  My souse ran and got on site medics who assessed me and reported it was the lymph nodes in my throat that were slightly swollen. They monitored me for about 10 minutes and since I could breathe and my air way was not obstructed, they said I could leave the site. I went home and about 30 minutes later I could swallow more regularly and the swelling had reduced.
ACUTE RESPIRATORY FAILURE 12/23/2021  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/31/2021  ACUTE ON CHRONIC RESPIRATORY FAILURE 12/31/2021  HYPOXIA 10/15/2021  ACUTE RESPIRATORY FAILURE 12/23/2021  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/31/2021  ACUTE ON CHRONIC RESPIRATORY FAILURE 12/31/2021  HYPOXIA 10/15/2021  ACUTE RESPIRATORY FAILURE 12/23/2021  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 12/31/2021  ACUTE ON CHRONIC RESPIRATORY FAILURE 12/31/2021  HYPOXIA 10/15/2021
Information has been received from a physician referring to an unspecified number of patients of unknown age and gender. On unspecified dates the patients were vaccinated with improperly stored doses of GARDASIL (lot # K016966, expiration date 10-MAY-2017, dose and route unknown), which were under the temperature of 24 degree Celsius with time frame 838 hours. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
freezing excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2021-2022 season) for prophylaxis and flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 30th September 2021, the patient received Havrix, FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix, FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were reported as follows: The age at vaccination was not reported. The reporter stated that the patient received a Havrix and Flulaval that had been exposed to freezing temperatures, which led to incorrect storage of drug. The reporter consented to follow-up.
This spontaneous report as received from a healthcare worker refers to a unspecified number of patients of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not reported. No previous drug reactions or allergies were reported. On an unknown date the unspecified number of patients were vaccinated with improperly stored GARDASIL 9 (dosing details were not reported) (lot # K026242 with an expiry date of 28-JAN-2017 exposed to 30 F for 37.68 hours), (lot # L004014 with an expiry date of 04-MAR-2017 exposed to 30 F for 16.93 hours) and (lot # L007560 with an expiry date of 15-JUN-2017 exposed to 30 F for 20.75 hours). No concomitant medications were reported. No adverse effects were reported. There was no product quality complaint involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Reoccurring, intermittent chest pains/chest wall pains, rated 6/10 unrelieved with medication or physician changes
? Day 10 after vaccine #1 upper lip swelling AKA angioedema ? Day 6 post vaccine #2 lower right lip and upper right lip swelling. Scratchy throat ? Day 10 post vaccine #2 wheezing like an asthma attack ? Day 12 post vaccine #2 Left, lower lip swelling, tingling in my tongue ? itchy for 2 weeks, 14 days post vaccine #2. Developed a sporadic, ever changing rash ? Day 16 post vaccine #2 a different, new rash
Pain extream for 3 days Broke out with extream Pain & Shingles all over my side TORSO so I opted out of getting second Shot did not want a worse condition !!!!   And keep getting eye infections & break out with fever blisters & had not had any issues for years so it was a very painful experience & will not ever get another shot or vaccine !!!